
At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
New Marketing & PR activity — 11 fresh signals just appeared.
The order this company entered each market — oldest to newest
Asymchem Basel Symposium
Asymchem Basel Symposium
Sign up to see the full signal feed
How Asymchem's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
AsymchemYou | 2 | 0 | +1000% | 12 | 33 |
Project Manager
View postingTianjin, China · 3w ago
Senior Process Engineer
View postingSandwich, England, United Kingdom · last mo.
Graduates & Postgraduates (China-based roles)
View postingTianjin, China · last mo.
AsymBio, an Asymchem Group subsidiary, launched its Fengxian commercial manufacturing site in Shanghai, completing its dual-site, one-center network for end-to-end biologics CDMO capabilities.
BioAQ 2026 summit in Shanghai focuses on biopharmaceutical analysis and quality control, featuring experts from top pharma companies and regulatory bodies.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Asymchem's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.